Abstract
Hypertension and type 2 diabetes mellitus (T2DM) cause endothelial dysfunction probably through increased oxidant stress. Paraoxonase (PON1) is an high-density lipoprotein (HDL)−linked anti-oxidant enzyme whose capacity is influenced by a genetic polymorphism at codon 192. In the present study we have investigated the role of PON1 polymorphism on endothelial function in subjects with T2DM with or without hypertension. Three groups of male subjects were enrolled: 65 healthy control subjects without T2DM or hypertension (CON), 51 with only T2DM (DM), and 67 with both hypertension and T2DM (HYP+DM). The PON1 Gln192Arg polymorphism was determined by polymerase chain reaction (PCR) amplification and restriction analysis. Endothelial function was evaluated as flow-mediated vasodilatation (FMD) of the brachial artery after forearm ischemia. Data were analyzed according to the presence or absence of the Arg allele. Subjects with T2DM had markedly impaired FMD, compared with those of the CON group. In the CON and HYP+DM groups no difference was observed in FMD between subjects homozygous for the Gln allele and those carrying the Arg allele. In the DM group FMD was lower among those carrying the Arg allele compared with Gln/Gln homozygotes (2.1±2.4% vs. 6.2±5.2%, p=0.002). In conclusion, the present findings demonstrated that FMD was less impaired in normotensive diabetic subjects homozygous for the Gln allele, consistent with the notion that this isoform has a more effective antioxidant action that serves to protect circulating low-density lipoprotein (LDL). Hypertension seems to abolish the protective effect of the Gln isoform. These findings, however, warrant further investigation to clarify their clinical import.
Similar content being viewed by others
Article PDF
References
Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA : Impaired nitric-oxide mediated vasodilatation in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567–574.
Evans M, Anderson RA, Graham J, et al: Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 2000; 101: 1773–1779.
Bagg W, Whalley GA, Gamble G, Drury PL, Sharpe N, Braatvedt GD : Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes. Intern Med J 2001; 31: 322–328.
Ravikumar R, Deepa R, Shanthirani C, Mohan V : Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (the Chennai Urban Population Study [CUPS-9]). Am J Cardiol 2002; 90: 702–707.
Kugiyama K, Kerns SA, Morisett JD, Roberts R, Henry PD : Impairment of endothelium-dependent arterial relaxation by lisolecithin in modified low-density lipoproteins. Nature 1990; 344: 160–162.
Simon BC, Cunningham LD, Cohen RA : Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990; 86: 75–79.
Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P : The effects of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488–493.
Taskinen MR : Pathogenesis of dyslipidemia in type 2 diabetes: Exp Clin Endocrinol Diabetes 2001; 109: 180–188.
Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS : Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 3212–3216.
Kopprasch S, Pietzsch J, Kuhlisch E, et al: In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002; 51: 3102–3106.
Landmesser U, Drexler H : Endothelial function and hypertension. Curr Opin Cardiol 2007; 22: 316–320.
Mackness MI, Arrol S, Abbott CA, Durrington PN : Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129–135.
Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN : Effect of the human serum paraoxonase 55 and 192 genetic polymorphism on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998; 423: 57–60.
Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parno SL, La Du B : Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581–1590.
Aviram M, Hardak E, Vaya J, et al: Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000; 101: 2510–2517.
Mackness MJ, Arrol S, Mackness B, Durrington PN : Alloenzymes of paraoxonase and effectiveness of high density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet 1997; 349: 851–852.
Yamane T, Matsumoto T, Nakae I, et al: Impact of paraoxonase polymorphism (Q192R) on endothelial function in intact coronary circulation. Hypertens Res 2006; 29: 417–422.
Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A : Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002; 62: 265–284.
Gnasso A, Motti C, Irace C, et al: The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs. Atherosclerosis 2002; 164: 289–295.
Irace C, Ceravolo R, Notarangelo L, et al: Comparison of endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound. Atherosclerosis 2001; 158: 53–59.
Frei B : On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 1999; 222: 196–204.
Paolisso G, Manzella D, Tagliamonte MR, et al: The BB-paraoxonase genotype is associated with impaired brachial reactivity after acute hypertriglyceridemia in healthy subjects. J Clin Endocrinol Metab 2001; 86: 1078–1082.
Tomiyama H, Kushiro T, Okazaki R, Yoshida H, Doba N, Yamashina A : Influences of increased oxidative stress on endothelial function, platelets function, and fibrinolysis in hypertension associated with glucose intolerance. Hypertens Res 2003; 26: 295–300.
Wheler JG, Keavney BD, Watkins H, Collins R, Danesh J : Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies. Lancet 2004; 363: 689–695.
Pfohl M, Koch M, Enderle MD, et al: Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes 1999; 48: 623–627.
Ruiz J, Blanche H, James RW, et al: Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346: 869–872.
Cosentino F, Luscher TF : Effects of blood pressure and glucose on endothelial function. Curr Hypertens Rep 2001; 3: 79–88.
Richter RJ, Furlong CE : Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999; 9: 745–753.
Mackness B, Davies GK, Turkie W, et al: Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 2001; 21: 1451–1457.
Mackness B, Durrington P, McElduff P, et al: Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003; 107: 2775–2779.
Crouse JR, Goldbourt U, Evans G, et al: Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort. Stroke 1996; 27: 69–75.
Lambert J, Aarsen M, Donker AJ, Stehouwer CD : Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 705–711.
Monnier VM, Kohn RR, Cerami A : Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A 1984; 81: 583–587.
Wautier JL, Wautier MP, Schmidt AM, et al: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A 1994; 91: 7742–7746.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Irace, C., Cortese, C., Fiaschi, E. et al. The Influence of PON1 192 Polymorphism on Endothelial Function in Diabetic Subjects with or without Hypertension. Hypertens Res 31, 507–513 (2008). https://doi.org/10.1291/hypres.31.507
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.507